Canadian CANNAINVESTOR Magazine Canada March / April 2019 | Page 114

OK. So let’s start the deep dive shall we? What separates you from the pack? If I am a patient or potential partner, why would your company not only be on my short list … but quite possibly the one I choose?

The simple answer has to do with our proprietary extraction method which produces a pharma-grade product that is consistency batch to batch and 99.5% activated. This enables consistent dosing, so patient will have a highly reproducible experience every time they consume our product. Let me explain the challenge in the market. here is a huge amount of variability in the products available in the market....harvest to harvest, and strain to strain. In addition to the inherit variability found in the plant, we are also observing a high degree of inconstancy in the activation of the cannabinoids. Most people know that the ingredients in the plant are inactive. If you ingest raw cannabis, it is not going to do a lot for you. You need to activate the ingredients through a process called decarboxylation – typically through smoking or vaping. In the case of non-smoked products, there has to be an activation step. We are seeing in the industry that there are inconsistent and hugely varied methods for activation. if you are a medical patient, with real pain, you need real treatment. And that means you have to be able to purchase product that is consistent from batch to batch.

Scientus has developed its own proprietary, patented process to do the extraction and decarboxylation in a single, efficient step. And we have product that is 99.5% activated every time. That platform technology enables us to provide more reliable and consistent cannabinoid products in a range of dosing forms from oils, capsules, tablets, buccal sprays and topicals.

recently, in the fall of 2018, we received our approvals to manufacture oils and capsules on a commercial scale. We are awaiting our approval to sell those oils and capsules, and expect that imminently.

114